129 related articles for article (PubMed ID: 27067505)
21. Nanozeolite bioconjugates labeled with
Piotrowska A; Męczyńska-Wielgosz S; Majkowska-Pilip A; Koźmiński P; Wójciuk G; Cędrowska E; Bruchertseifer F; Morgenstern A; Kruszewski M; Bilewicz A
Nucl Med Biol; 2017 Apr; 47():10-18. PubMed ID: 28043005
[TBL] [Abstract][Full Text] [Related]
22. [Survival of newly diagnosed malignant glioma patients on combined modality therapy].
Yang QY; Shen D; Sai K; Jiang XB; Ke C; Zhang XH; Mou YG; Chen ZP
Zhonghua Yi Xue Za Zhi; 2013 Jan; 93(1):8-10. PubMed ID: 23578444
[TBL] [Abstract][Full Text] [Related]
23. Resection, biopsy, and survival in malignant glial neoplasms. A retrospective study of clinical parameters, therapy, and outcome.
Devaux BC; O'Fallon JR; Kelly PJ
J Neurosurg; 1993 May; 78(5):767-75. PubMed ID: 8468607
[TBL] [Abstract][Full Text] [Related]
24. Outcome of children with centrally reviewed low-grade gliomas treated with chemotherapy with or without radiotherapy on Children's Cancer Group high-grade glioma study CCG-945.
Fouladi M; Hunt DL; Pollack IF; Dueckers G; Burger PC; Becker LE; Yates AJ; Gilles FH; Davis RL; Boyett JM; Finlay JL
Cancer; 2003 Sep; 98(6):1243-52. PubMed ID: 12973849
[TBL] [Abstract][Full Text] [Related]
25. Stereotactic brachytherapy with iodine-125 seeds for the treatment of inoperable low-grade gliomas in children: long-term outcome.
Ruge MI; Simon T; Suchorska B; Lehrke R; Hamisch C; Koerber F; Maarouf M; Treuer H; Berthold F; Sturm V; Voges J
J Clin Oncol; 2011 Nov; 29(31):4151-9. PubMed ID: 21969508
[TBL] [Abstract][Full Text] [Related]
26. Insular glioma resection: assessment of patient morbidity, survival, and tumor progression.
Sanai N; Polley MY; Berger MS
J Neurosurg; 2010 Jan; 112(1):1-9. PubMed ID: 19612970
[TBL] [Abstract][Full Text] [Related]
27. Radiotherapy for high-grade gliomas. Does altered fractionation improve the outcome?
Nieder C; Andratschke N; Wiedenmann N; Busch R; Grosu AL; Molls M
Strahlenther Onkol; 2004 Jul; 180(7):401-7. PubMed ID: 15241527
[TBL] [Abstract][Full Text] [Related]
28. Chemotherapy for treatment of grade II gliomas.
Strowd RE; Holdhoff M; Grossman SA
Oncology (Williston Park); 2014 Dec; 28(12):1036-43. PubMed ID: 25510803
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of systemic radionuclide therapy with p-131I-iodo-L-phenylalanine combined with external beam photon irradiation in treating malignant gliomas.
Samnick S; Romeike BF; Lehmann T; Israel I; Rübe C; Mautes A; Reiners C; Kirsch CM
J Nucl Med; 2009 Dec; 50(12):2025-32. PubMed ID: 19910430
[TBL] [Abstract][Full Text] [Related]
30. Current status of local therapy in malignant gliomas--a clinical review of three selected approaches.
Juratli TA; Schackert G; Krex D
Pharmacol Ther; 2013 Sep; 139(3):341-58. PubMed ID: 23694764
[TBL] [Abstract][Full Text] [Related]
31. Low-grade gliomas of the cerebral hemispheres in children: an analysis of 71 cases.
Pollack IF; Claassen D; al-Shboul Q; Janosky JE; Deutsch M
J Neurosurg; 1995 Apr; 82(4):536-47. PubMed ID: 7897512
[TBL] [Abstract][Full Text] [Related]
32. Tumor imaging and therapy using radiolabeled somatostatin analogues.
de Jong M; Breeman WA; Kwekkeboom DJ; Valkema R; Krenning EP
Acc Chem Res; 2009 Jul; 42(7):873-80. PubMed ID: 19445476
[TBL] [Abstract][Full Text] [Related]
33. Comparison between contrast-enhanced magnetic resonance imaging and technetium 99m glucohepatonic acid single photon emission computed tomography with histopathologic correlation in gliomas.
Kumar RA; Khandelwal N; Sodhi KS; Pathak A; Mittal BR; Radotra BD; Suri S
J Comput Assist Tomogr; 2006; 30(5):723-33. PubMed ID: 16954918
[TBL] [Abstract][Full Text] [Related]
34. Long-Term Results of Targeted Low-Grade Glioma Treatment with
Cordier D; Merlo A
Cancer Biother Radiopharm; 2019 Aug; 34(6):413-416. PubMed ID: 30844298
[TBL] [Abstract][Full Text] [Related]
35. Association between fluorine-18-labeled fluorodeoxyglucose uptake and 1p and 19q loss of heterozygosity in World Health Organization Grade II gliomas.
Stockhammer F; Thomale UW; Plotkin M; Hartmann C; Von Deimling A
J Neurosurg; 2007 Apr; 106(4):633-7. PubMed ID: 17432715
[TBL] [Abstract][Full Text] [Related]
36. Survival following surgery and prognostic factors for recently diagnosed malignant glioma: data from the Glioma Outcomes Project.
Laws ER; Parney IF; Huang W; Anderson F; Morris AM; Asher A; Lillehei KO; Bernstein M; Brem H; Sloan A; Berger MS; Chang S;
J Neurosurg; 2003 Sep; 99(3):467-73. PubMed ID: 12959431
[TBL] [Abstract][Full Text] [Related]
37. A prospective Phase II clinical trial of 5-aminolevulinic acid to assess the correlation of intraoperative fluorescence intensity and degree of histologic cellularity during resection of high-grade gliomas.
Lau D; Hervey-Jumper SL; Chang S; Molinaro AM; McDermott MW; Phillips JJ; Berger MS
J Neurosurg; 2016 May; 124(5):1300-9. PubMed ID: 26544781
[TBL] [Abstract][Full Text] [Related]
38. Long-term prognostic assessment of 185 newly diagnosed gliomas: Grade III glioma showed prognosis comparable to that of Grade II glioma.
Shinohara C; Muragaki Y; Maruyama T; Shimizu S; Tanaka M; Kubota Y; Oikawa M; Nakamura R; Iseki H; Kubo O; Takakura K; Hori T
Jpn J Clin Oncol; 2008 Nov; 38(11):730-3. PubMed ID: 18820008
[TBL] [Abstract][Full Text] [Related]
39. Morphological aspects of the hepatic response to neoadjuvant therapy.
Fernández-Aceñero MJ; Cortés-Guiral D; Muñoz LE; Martínez-Useros J; Pastor-Idoate C
Pathol Res Pract; 2015 Sep; 211(9):665-70. PubMed ID: 26163186
[TBL] [Abstract][Full Text] [Related]
40. Paediatric high and low grade glioma: the impact of tumour biology on current and future therapy.
Hargrave D
Br J Neurosurg; 2009 Aug; 23(4):351-63. PubMed ID: 19637006
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
